Zobrazeno 1 - 10
of 124
pro vyhledávání: '"M. Ciccarese"'
Autor:
B. Trevisan, F. F. Pepe, I. Vallini, E. Montagna, D. Amoroso, R. Berardi, A. Butera, K. Cagossi, L. Cavanna, M. Ciccarese, S. Cinieri, E. Cretella, E. De Conciliis, A. Febbraro, F. Ferraù, A. Ferzi, A. Baldelli, A. Fontana, A. R. Gambaro, O. Garrone, V. Gebbia, D. Generali, L. Gianni, F. Giovanardi, A. Grassadonia, V. Leonardi, S. Sarti, A. Musolino, M. Nicolini, C. Putzu, F. Riccardi, D. Santini, M. G. Sarobba, M. G. Schintu, G. Scognamiglio, P. Spadaro, C. Taverniti, D. Toniolo, P. Tralongo, A. Turletti, R. Valenza, M. R. Valerio, P. Vici, L. Clivio, V. Torri, M. E. Cazzaniga, The VICTOR Study Group
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Nowadays, treatment of metastatic breast cancer (MBC) has been enriched with novel therapeutical strategies. Metronomic chemotherapy (mCHT) is a continuous and frequent administration of chemotherapy at a lower dose and so whit less toxicity
Externí odkaz:
https://doaj.org/article/ead6e1b17648435a854ffe97bf17b72e
Autor:
M. E. Cazzaniga, L. Cortesi, A. Ferzi, L. Scaltriti, F. Cicchiello, M. Ciccarese, S. Della Torre, F. Villa, M. Giordano, C. Verusio, M. Nicolini, A. R. Gambaro, L. Zanlorenzi, E. Biraghi, E. Casini, L. Legramandi, E. Rulli
Publikováno v:
International Journal of Breast Cancer, Vol 2017 (2017)
Triple-negative breast cancer (TNBC) shows a very bad prognosis, even in early stages of disease. Metronomic chemotherapy refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen with no prolonged
Externí odkaz:
https://doaj.org/article/a530eb83e98140638779f75caa91f5b0
Autor:
M.E. Cazzaniga, G. Pinotti, E. Montagna, D. Amoroso, R. Berardi, A. Butera, K. Cagossi, L. Cavanna, M. Ciccarese, S. Cinieri, E. Cretella, E. De Conciliis, A. Febbraro, F. Ferraù, A. Ferzi, G. Fiorentini, A. Fontana, A.R. Gambaro, O. Garrone, V. Gebbia, D. Generali, L. Gianni, F. Giovanardi, A. Grassadonia, V. Leonardi, P. Marchetti, E. Melegari, A. Musolino, M. Nicolini, C. Putzu, F. Riccardi, D. Santini, S. Saracchini, M.G. Sarobba, M.G. Schintu, G. Scognamiglio, P. Spadaro, C. Taverniti, D. Toniolo, P. Tralongo, A. Turletti, R. Valenza, M.R. Valerio, P. Vici, L. Clivio, V. Torri, F. Cicchiello, F. Riva, I. Vallini, M. Mazza, C. Bonfadini, E. Bordin, M. Canicattì, F. Cappuccio, E. Collovà, C. De Angelis, R. Desorte, S. Donati, G. Drudi, D. Galanti, C. Mocerino, L. Orlando, B. Pellegrino, L. Pizzuti, C. Ridolfi, A. Rocca, D. Sarti, I. Spagnoletti, N. Tinari, A. Vandone, L. Vizzini
Publikováno v:
The Breast. 48:7-16
Metronomic chemotherapy (mCHT) refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen, with no prolonged drug-free breaks, that leads to antitumor activity. Aim of the present study is to descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ccc55ffe369bd59a71be4bd8fc5969
https://doi.org/10.1016/j.breast.2019.07.006
https://doi.org/10.1016/j.breast.2019.07.006
Autor:
E. Quarta, D. Ciardo, Fiorella Anna Lombardi, Antonella Grimaldi, R. Forcignanò, M. Ciccarese, M. Di Paola, Sergio Casciaro, Paola Pisani, Maurizio Muratore, Francesco Conversano
Publikováno v:
Annals of the Rheumatic Diseases. 79:1187.2-1188
Background:Aromatase inhibitor (AI) therapy in women with estrogen receptor-positive (ER+) breast cancer (BC) causes accelerated bone loss and increased risk of osteoporosis and fractures as side effects. Denosumab (i.e. 60 mg twice a year) is a viab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37faac27141ef2890be9d42171cc906e
https://doi.org/10.1136/annrheumdis-2020-eular.3806
https://doi.org/10.1136/annrheumdis-2020-eular.3806
Autor:
Domenico De Berardis, Duccio Papanti, A. Guiguis, John Corkery, M. Ciccarese, Laura Orsolini, Fabrizio Schifano
Publikováno v:
European Neuropsychopharmacology. 29:S472-S473
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6da8db22385951aab38174a037b7cdb
https://doi.org/10.1016/j.euroneuro.2018.11.705
https://doi.org/10.1016/j.euroneuro.2018.11.705
Autor:
E. Quarta, M. Ciccarese, Francesco Conversano, Maurizio Muratore, M. Di Paola, Giammarco Surico, R Tarparelli, Ernesto Casciaro, D. Costanza, Paola Pisani, R. Franchini, R. Forcignanò, L. Quarta, Sergio Casciaro
Publikováno v:
Poster Presentations.
Background The Aromatase Inhibitors (AIs)-based therapy used in breast cancer patients to profoundly lower estrogen levels seems to enhance the loss of bone mineral density (BMD) and to increase the fragility fracture rate [1]. Several clinical studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02fe1c66d98bf6a7e3ebeef6e41933f0
https://doi.org/10.1136/annrheumdis-2017-eular.4060
https://doi.org/10.1136/annrheumdis-2017-eular.4060
Autor:
Paolo Dessole, Rita Pasqualina Satta, M. Ciccarese, Giacomina Loriga, Pier Giorgio Pala, Giovanna Serra, Vincenzo Fanelli, Maria Laura Cossu, Maria Luisa Manca
Publikováno v:
Transplantation Proceedings. 42:1297-1302
Background. In large-scale clinical trials, the proliferation signal inhibitor (PSI) everolimus (EVL) combined with cyclosporine (CsA) and steroids, has been shown to be efficacious among de novo renal transplant recipients. Development of proteinuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720aebf88336cf85d0397d7420921602
https://doi.org/10.1016/j.transproceed.2010.03.120
https://doi.org/10.1016/j.transproceed.2010.03.120
Autor:
Gm Cherchi, P. Brizzi, Maria G. Melis, Margherita Maioli, A. Carboni, Marilena Formato, G. Tonolo, M. F. Angius, M. Ciccarese
Publikováno v:
European Journal of Clinical Investigation. 30:980-987
Background Experimental evidence indicates that statins might have direct vascular effects independently from low-density lipoprotein (LDL) cholesterol reduction and we reported that the reduction in urinary albumin excretion rate during Simvastatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95c5973afa88ebd6e4bae8c7653c8e76
https://doi.org/10.1046/j.1365-2362.2000.00735.x
https://doi.org/10.1046/j.1365-2362.2000.00735.x
Autor:
Romano Nosadini, Alois Saller, Fabiana Filigheddu, Mario Maioli, Giancarlo Tonolo, P. Pinna-Parpaglia, Nicola Glorioso, Franco Mantero, P. P. Faronato, M. Ciccarese, A. Soro, Chiara Troffa, Francesco Dettori, Enrico Brocco
Publikováno v:
Journal of Endocrinological Investigation. 22:760-765
In a large cohort (no. = 361) of NIDDM probands and their concordant/discordant siblings from no. = 132 families we studied: 1. the levels of plasma prorenin in non affected siblings of NIDDM probands as opposed to normal subjects without family hist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef638a8cfbb59e80616aec4fd43b6da7
https://doi.org/10.1007/bf03343641
https://doi.org/10.1007/bf03343641
Autor:
Mario Maioli, Giannina Secchi, Giancarlo Tonolo, Antonello Malavasi, Maria Filippina Angius, Maria G. Melis, Antonello Carboni, M. M. Atzeni, M. Ciccarese
Publikováno v:
Journal of Hypertension. 17:33-38
OBJECTIVE To evaluate the possible association of three candidate gene polymorphisms with essential hypertension in the genetically homogeneous Sardinian population. SUBJECTS AND METHODS We studied 494 unrelated, nondiabetic subjects, 213 (43.2%) wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2804b81c4454f7212d3a75fe574ff7db
https://doi.org/10.1097/00004872-199917010-00006
https://doi.org/10.1097/00004872-199917010-00006